Lin Gan, Ph.D.

Lin Gan, Ph.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 659
Rochester, NY 14642

Appointment: (585) 275-URMC (8762)

Patient Care Bio

Degenerative eye diseases such as age-related macular degeneration (AMD), glaucoma, and retinitis pigmentosa (RP), lead to blindness due to the permanent loss of nerve cells (neurons) in the eye's retina, and pose great public health risks. Since the degeneration of retinal neurons is an irreversible process, no cure is currently available. To understand what lead to the retinal neuronal death and to develop cures to these diseases, my research is focused on two major directions:



1. Stem cell regeneration and retinal development: One promising remedy for retinal degeneration diseases is to implant stem cells or retinal precursor cells in the retina to regenerate retinal neurons. Our studies in this area are focused in identifying genes and genetic processes essential for the generation of retinal neurons from stem cells. Studies in my laboratory have already identified many genes essential for the regulation of stem cell to retinal neuron transition. We will use these genes and processes as biomarkers to optimize the culture conditions that facilitate the transition of stem cells to retinal neurons. These studies will provide the foundation for retinal regeneration.

2. Retinal neuro-protection, gene therapy, and drug development: Though the death of neurons is the final, irreversible process of retinal degeneration diseases, retinal neurons are insulted or sick for extended periods of time before their death is triggered. Therefore, in addition to early diagnosis, it is critical to understand the early changes in retinal neurons that trigger cell death, and to develop treatments that could slow down or protect the retinal neurons from further damage and death. Using genetic and genomic approaches, my laboratory has identified several genes that are essential for the survival of retinal neurons and has demonstated that the function of these genes are affected early in animal models of retinal degeneration diseases. Currently, we are exploring the treatment of retinal degeneration in animal models using modified viruses to deliver these genes into retinal neurons. Additionally, we are screening for small molecules (drugs) that can regulate these genes and treat retinal degeneration.

Awards & Honors

Research to Prevent Blindness Senior Scientific Investigator Award | Research to Prevent Blindness 2011 - 2011
NIH (RO1 DC008856) Function of LIM-domain Transcriptional Regulators in Inner Ear Development. | NIH/NIDCD 2008 - 2013
NIH RO1 (1R01DC009250), Sensory Organ Formation in the Inner Ear | NIH/NIDCD (Co-PI) 2008 - 2013
NEI (RO1 EY015551), Brn3b Transcription Factors in Retinal Development | NIH/NEI 2004 - 2010
NEI (2 RO1 EY013426), "Function of Math5 in Retinal Development." | NIH/NEI 2001 - 2011
Rosanne H. Silbermann Fellow | Silbermann Foundation 1999 - 2003
CUSBEA (China-United States Biochemistry and Molecular Biology Examination and Administration) Program Scholarship | Ministry of Education | China 1985

Current Appointments

Dean's Professorship - Department of Ophthalmology (SMD)
Professor - Department of Ophthalmology (SMD) - Primary
Professor - Department of Center for Visual Science A&S (RC)
Professor - Department of Neurobiology and Anatomy (SMD)

Education

PhD | Biochemistry, All Other | U Tex-Houstn Grad Sch Biomd Sc1992
BS | Biochemistry, All Other | China - Non-Medical School1985

Post-Doctoral Training & Residency

Postdoctoral Fellow (with William Klein, Ph.D.), Dept. of Biochemistry and Molecular Biology, Univ. of Texas M.D. Anderson Cancer Center 1994